Upgrade to SI Premium - Free Trial

Caris Life Sciences Inc (CAI) PT Lowered to $22 at Canaccord

March 13, 2026 6:11 AM
Canaccord analyst Kyle Mikson lowered the price target on Caris Life Sciences Inc (NASDAQ: CAI) to $22.00 (from $30.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change